top of page
GOLD-26-Website-Homepage-Banner-2023.jpg
  • LinkedIn
  • Black YouTube Icon

NEW ISSUE OF GOLD 

OUT NOW! 

Check out the new issue of GOLD! From the exodus of pharma marketers from Twitter to integrating artificial intelligence into medical affairs, this issue explores how the industry is evolving with changing environments for the benefit of customers and patients.

Anchor 2

Catalyst of pharma 

Mina Makar

Catalyst-Mina-Makar-AstraZeneca.jpg

Mina Makar, Senior Vice President, Global Cardiovascular, Renal and Metabolism, AstraZeneca, talks about solving unmet needs and how to champion the patient perspective.

Cover feature

A takeover, a tweet and trouble for pharma marketers

Pharma-Twitter-exodus.jpg

Many top pharma companies have cut their Twitter ad spending after the Eli Lilly scandal, but should they take a risk and return to the platform?

Editor's Picks
Ed's Pick

Editor's Picks

Opinion

5 ways pharma can ensure omnichannel success
Davidek-Herron-Roche.jpg

Roche’s Davidek Herron and two of his colleagues offer five top tips for pharma marketers striving for omnichannel excellence.

Medical Affairs

Mastering medical affairs
MSc-in-medical-affairs.jpg

Medical affairs is becoming increasingly complex, but industry-academia collaboration aims to tackle this head on.

International

Pharma in Poland
Pharma-in-Poland.jpg

Travel to Poland to discover the factors driving the nation's pharmerging status and access to medicine challenges.

Anchor 1

Infographic

Attracting diverse
talent into STEM

This infographic explores how the top pharma companies rank in the diversity, equity and inclusion stakes and their mission to attract the future STEM workforce.

GOLD 26 Infographic.jpg

Never miss a GOLD update, subscribe! 

bottom of page